Hjem › Hjerteanfald › New Jersey
Hjerteanfald kliniske forsøg i New Jersey
5 studier for Hjerteanfald søger deltagere på steder i New Jersey.
Officiel studietekst (engelsk)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Hypertension & Nephrology Association, Eatontown
- New Jersey Kidney Care, Jersey City
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- The Valley Hospital, Ridgewood
- Overlook Medical Center, Summit
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 4. sep. 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Advanced Heart Care LLC, Bridgewater
- Advanced Heart and Vascular Institute of Hunterdon, Flemington
- Clinical Reseach Philadelphia Pennington, Hamilton
- og 7 flere
RekruttererFase 3
Alder 50 til 105 · Alle køn · Opdateret 21. aug. 2026 · NCT07136012AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Hackensack University Medical Center, Hackensack
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 1. jun. 2026 · NCT06699056Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Rutgers University, Newark
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. mar. 2026 · NCT04774159Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.